About Us
Science
Pipeline
Investors
Contact
Media Coverage
Any Year
September 29, 2025
Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment
MedCity News
September 29, 2025
Ernexa Therapeutics: Interview With President & CEO Sanjeev Luther About The Innovative Cell Therapy Company
Pulse 2.0
September 17, 2025
Press Release Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research
FirstWord Pharma
September 11, 2025
Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther
Cell & Gene Podcast
September 5, 2025
Rethinking Clinical Development In The Age Of Synthetic Cell Therapy
Clinical Leader
July 30, 2025
MSCs Rising
Cell & Gene Therapy Review
July 24, 2025
Next-Gen Delivery Systems for Genetic Drug Market Driven by Viral and Non-Viral Vector Innovation
Precedence Research
June 2, 2025
ASCO: Ernexa's 'Trojan Horse' stem cell therapy shrinks ovarian tumors in mice
Fierce Biotech
June 2, 2025
ASCO: Ernexa’s ‘Trojan Horse’ stem cell therapy shrinks ovarian tumors in mice
Boston Cambridge BioTech Networks
May 14, 2025
The mesenchymal stem cell’s superpower: Hacking the TME
Pharmaphorum
1 of 4
